Skip to main content
. 2019 Jul 29;41(1):704–717. doi: 10.1080/0886022X.2019.1642210

Figure 6.

Figure 6.

Respective and combined contributions of miR-193a, WT1, and PODXL to appraising renal survival of IMN patients at stage II.